We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 May 2017 14:25

RNS Number : 4485F
Maven Income & Growth VCT 4 PLC
17 May 2017
 

 

Maven Income and Growth VCT 4 PLC

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 10.30 am at Fifth Floor, 1-2 Royal Exchange Buildings, London, EC3V 3LF on 17 May 2017, all of the Resolutions put to the Meeting were duly passed.

 

At the record date for the Annual General Meeting, being 15 May 2017, the total number of voting rights in the Company stood at 32,767,502 Ordinary Shares. In accordance with the provisions of E.2.2 of the UK Corporate Governance Code, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 3,972,861 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements.

3,854,111

104,885

0

13,865

3,972,861

2

To approve the Directors' Remuneration Report.

2,873,170

97,294

959,122

43,275

3,972,861

3

To approve the Directors' Remuneration Policy.

3,331,703

108,526

487,511

45,121

3,972,861

4

To approve a final dividend.

3,863,639

104,762

4,460

0

3,972,861

5

To re-elect Mr Cormack as a Director.

3,658,262

116,948

167,229

30,422

3,972,861

6

To re-elect Mr Graham-Wood as a Director.

3,654,209

122,020

166,210

30,422

3,972,861

7

To re-elect Mr Scott as a Director.

3,734,401

132,901

75,137

30,422

3,972,861

8

To re-elect Mr Nixon as a Director.

3,718,182

151,281

77,744

25,654

3,972,861

9

To re-appoint Deloitte LLP as Auditor.

3,420,186

160,474

380,571

11,630

3,972,861

10

To authorise the Directors to fix the remuneration of the Auditor.

3,794,009

141,724

17,998

19,130

3,972,861

11

To authorise the Directors to allot new shares.

3,787,895

131,600

22,735

30,631

3,972,861

12

To authorise disapplication of pre-emption rights.

3,627,875

131,600

125,146

88,240

3,972,861

13

To authorise the Company to purchase its own shares.

2,985,482

124,556

846,392

16,431

3,972,861

14

To allow a General Meeting to be called on not less than 14 days' notice.

3,446,170

387,084

117,313

22,294

3,972,861

 

The Board notes that Resolution 2, an Ordinary Resolution relating to the approval of the Directors' Remuneration Report, was duly passed but recognises that a significant minority of Shareholders have voted against the Resolution. It is intended that the Remuneration Committee will give this due consideration in its future deliberations

 

The Directors also note that Resolution 13, a Special Resolution relating to the buying back of shares, was duly passed, but once again recognise that a significant minority of Shareholders have voted against the Resolution. It is intended that the Board will consider the views expressed by Shareholders when it next seeks such an authority.

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. These proxy voting figures will also be available to view at: www.mavencp.com/migvct4.

 

 

 

 

Passing of Resolutions under Special Business

Copies of Resolutions passed under Special Business have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

17 May 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGBXGDUXDBBGRR
Date   Source Headline
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:48 pmRNSIssue of Equity
27th Mar 202410:39 amRNSIssue of Equity
25th Mar 202410:14 amRNSStatement re Offer for Subscription
19th Mar 20245:03 pmRNSTransaction in Own Shares
20th Feb 20242:48 pmRNSDividend Declaration
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:10 amRNSIssue of Equity
17th Jan 202410:03 amRNSDirector/PDMR Shareholding
17th Jan 202410:02 amRNSDirector/PDMR Shareholding
17th Jan 20249:58 amRNSIssue of Equity
15th Jan 20244:28 pmRNSUnaudited Net Value Asset
15th Nov 20235:06 pmRNSTransaction in Own Shares
9th Nov 20233:53 pmRNSNet Asset Value(s)
9th Nov 20233:49 pmRNSResult of General Meeting
13th Oct 20234:56 pmRNSPublication of a Prospectus
13th Oct 202310:17 amRNSDirector/PDMR Shareholding
13th Oct 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
6th Oct 20232:39 pmRNSStatement re Dividend Investment Scheme
8th Sep 20235:01 pmRNSTransaction in Own Shares-Corrective announcement
7th Sep 20233:35 pmRNSTransaction in Own Shares
30th Aug 20232:02 pmRNSHalf-year Report
17th Aug 20233:26 pmRNSStatement re NAV and Interim Dividend
12th Jul 20234:09 pmRNSHolding(s) in Company
10th Jul 20235:06 pmRNSHolding(s) in Company
2nd Jun 202310:05 amRNSDirector/PDMR Shareholding
2nd Jun 20239:43 amRNSIssue of Equity
24th May 20235:10 pmRNSTransaction in Own Shares
23rd May 202310:18 amRNSDirector/PDMR Shareholding
23rd May 202310:17 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20233:38 pmRNSNet Asset Value(s) - Dividend Investment Scheme
11th May 20233:01 pmRNSResult of AGM
11th May 20232:20 pmRNSNet Asset Value(s)
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
13th Apr 20237:00 amRNSAnnual Financial Report
5th Apr 202312:36 pmRNSDirector/PDMR Shareholding
5th Apr 202312:30 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
21st Mar 20234:08 pmRNSTransaction in Own Shares
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:11 pmRNSUnaudited NAV and Proposed Final Dividend
21st Feb 20233:10 pmRNSUnaudited Net Asset Value, Proposed Final Dividend
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 202310:17 amRNSDirector/PDMR Shareholding
8th Feb 20239:44 amRNSIssue of Equity
3rd Feb 20233:12 pmRNSProvisional Net Asset Value
23rd Nov 20224:53 pmRNSTransaction in Own Shares
10th Nov 20223:33 pmRNSNet Asset Value(s)
9th Nov 20223:02 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.